Thrombosis
News
Smokers with PE have higher rate of hospital readmission
NEW ORLEANS – The rate of readmission within 30 days was significantly higher among PE patients with tobacco...
Clinical
Aspirin for primary prevention reduces risk of CV events, increases bleeding
What is the association between aspirin for primary prevention and cardiovascular events and bleeding?
All Content
Patient-reported complications regarding PICC lines after inpatient discharge
What signs and symptoms of possible complications are observed in patients who undergo placement of a peripherally inserted central catheter (PICC...
Clinical
How should anticoagulation be managed in a patient with cirrhosis?
Patients with chronic liver disease have a risk of VTE similar to (or even greater than) that of general medical patients.
News
FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients
The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.
News
Ticagrelor monotherapy tops DAPT for high-risk PCI patients
SAN FRANCISCO – TWILIGHT findings support move to shorter DAPT.
Clinical
Apixaban prevents clots with cancer
Does apixaban therapy decrease venous thromboembolism (VTE) in ambulatory patients with cancer at intermediate to high risk who are starting...
Clinical
Reversal agents for direct-acting oral anticoagulants
DOACs are increasingly prescribed for anticoagulation, thanks to its multiple advantages.
News
Older IBD patients are most at risk of postdischarge VTE
Readmission for venous thromboembolism in patients with inflammatory bowel diseases most often occurs within 60 days of discharge.
Clinical
Use of a CDSS increases safe outpatient management of low-risk PE patients
Does the use of an electronic clinical decision support system (CDSS) increase the number of low-risk patients with acute pulmonary embolism (PE)...